Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on May 1, 2025

electroCore’s Truvaga™ Now Works with the Apple Health app
ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now works with the Apple® Health app. …

Bitdeer Announces First Quarter 2025 Earnings Conference Call for May 15, 2025
SINGAPORE, May 01, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for Bitcoin mining, today announced that it has scheduled its first quarter 2025 earnings conference call …

Greif to Close Los Angeles Paperboard Mill
DELAWARE, Ohio, May 01, 2025 (GLOBE NEWSWIRE) -- Greif (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today it will permanently close the paperboard mill in Los Angeles, California as part of its previously …

Four in 10 Consumers Now Expect Personalized Marketing Experiences
CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) -- Nearly four in 10 U.S. consumers (39%) expect brands to personalize their online shopping experience with tailored interactions, product recommendations and marketing that align with individual preferences and …

Aemetis Biogas Completes $1.6 million of LCFS and D3 RIN Sales in April
CUPERTINO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced today that the Aemetis Biogas subsidiary of the company completed $1.6 million of sales of …

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
BASKING RIDGE, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious …

Canadians reveal top priorities when fleeing disasters: Top 3 things people would grab
MISSISSAUGA, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- As wildfires, floods, and extreme storms threaten more Canadian communities each year, a new survey from First Onsite Property Restoration reveals what Canadians would grab first when disaster strikes— …

Methanex Announces the Successful Restart of Geismar 3
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (Nasdaq:MEOH) announced today that its 1.8 million tonne methanol plant, Geismar 3 (G3), in Geismar, Louisiana has successfully restarted and begun producing …

Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia
HALIFAX, Nova Scotia, May 01, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today …

Parker Reports Fiscal 2025 Third Quarter Results
CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended March 31, 2025, that included the following highlights (compared with the …

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its first quarter 2025 financial …

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on …

Hubbell Reports First Quarter 2025 Results
Shelton, CT, May 01, 2025 (GLOBE NEWSWIRE) -- HUBBELL REPORTS FIRST QUARTER 2025 RESULTS Q1 diluted EPS of $3.15; adjusted diluted EPS of $3.50 Q1 net sales -2% (organic -0.6%; foreign exchange -0.6%; net M&A -1.2%) Q1 operating margin 17.5%; adjusted …

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
Study ANAVEX3-71-SZ-001 successfully completes enrollment with a total of 71 participants Both Part A (16 participants) and Part B (55 participants) of the placebo-controlled Phase 2 study fully enrolled Top line data expected in the second half of 2025 …

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025
GAITHERSBURG, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the …

Azucar Announces the Option of Three Projects in Nevada, USA from Almadex Minerals
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Azucar Minerals Ltd. ("Azucar" or the "Company") (TSX-V: AMZ; OTCQB: AXDDF) announces that it has signed an Option-Joint venture exploration agreement (the “Option”) with Almadex Minerals Ltd. …

Prelude Therapeutics to Participate in Citizens Life Sciences Conference
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking …

Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free Operations and Reports April 2025 Production Results
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is …

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC
As SVP, Neuroscience, Dr. Bordey will lead Cassava’s ongoing research and development efforts Dr. Bordey to direct the scientific evaluation of simufilam in TSC-related epilepsy, and potentially additional pipeline indications AUSTIN, Texas, May 01, 2025 ( …

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration
WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration Geneva, Switzerland, May 1, 2025 –WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading …